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Abstract 
 
Background: Jieyuanshen decoction (JYAS-D) - a traditional Chinese medicine was invented by Professor Nie based 
on classic formulas, chaihu jia longgu muli decoction has been proved as having favorable curative effects on 
depression in clinical practices. The aim of this study was to investigate the antidepressant effects and its molecular 
mechanism of JYAS-D.  
Materials and Methods: The model of depression was established by Chronic Unpredictable Stress. Different doses 
(8.2 g/kg, 16.3 g/kg, 32.7 g/kg) of JYAS-D was orally administered; Fluoxetine was orally administered with 10mg/kg. 
All treatments lasted for 28 days. Sucrose preference and open-field tests were adopted to observe the behavior of rats. 
OPA (ortho-phthalaldehyde) derivatization method was used to detect the contents of amino acid neurotransmitter. RIA 
(Radiation immunity analysis) method was used to measure the serum concentrations of CORT (Corticosterone), 
ACTH (Adrenocorticotropic hormone) and CRH (Corticotropin-releasing hormone). ELISA (Enzyme linked 
immunosorbent assay) method was adopted to examine the contents of Glucocorticoid receptor (GR) and 
Mineralocorticoid receptor (MR) in hippocampus. 
Results: Compared with the model group, sucrose preference was increased in all treatment groups. The concentration 
of serum CORT was reduced in the middle dose of JYAS-D and control groups; the concentration of serum ACTH was 
reduced in the low and high-dose of JYAS-D; the concentration of serum CRH was reduced in the middle and 
high-dose of JYAS-D. The content of hippocampus GR was increased in the middle and high-dose of JYAS-D; the 
content of hippocampus Glu (Glutamic acid) was reduced among the low, middle and high-dose of JYAS-D and 
fluoxetine group, the ratio of Glu/γ-GABA (γ-aminobutyric acid was reduced in the low and high-dose of JYAS-D.  
Conclusion: JYAS-D had a significant antidepressant-like effect on rat model through regulating serum concentration 
of CORT, ACTH and CRH, increasing the content of hippocampus GR and regulating the equilibrium of amino acids 
neurotransmitter.   
 
Key words: Hypothalamic-pituitary-adrenal (HPA) axis; Glucocorticoid/Mineralocorticoid receptor (G/MR); Amino 
acid neurotransmitter; Chronic Unpredictable Stress (CUS); Jieyuanshen decoction(JYAS-D).  
 
Introduction 
 
Depression is one of the most prevalent public mental health problems (Wang et al., 2015) which will cause the 
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highest burden in the middle and high income countries by the year 2030 according to WHO’s prediction. 
Antidepressant medications, including tricyclic antidepressants, selective serotonin reuptake inhibitors, serotonin and 
norepinephrine reuptake inhibitors, and dopamine reuptake inhibitors, have been used to treat depression for over half a 
century. Although these antidepressant medications represent the mainstay therapy for depression, almost one-quarter 
of the patients fail to respond to these therapeutics (Kupfer et al., 2012). Therefore, attempts are being made to seek 
alternative medication. The history of treating depression with Chinese traditional medicine is more than a thousand 
years. Chinese herb has been proved efficacious, stable with few side effects. Thus it draws more attention of scientists 
who are engaged in treating depression. 
 Nie Huimin, one of Beijing Physician Masters of Chinese Medicine, is a famous professor and doctor in 
Beijing university of Traditional Chinese Medicine who is good at treating depression with Chinese herbs. Jieyuanshen 
decoction (JYAS-D) which had favorable curative effects on depression in clinical practices was invented by Professor 
Nie based on classic formulas, chaihu jia longgu muli decoction. It is also one of formulas popularized by Ministry of 
Science and Technology of People's Republic of China National Economic and Social Development 11th Five-Year 
Plan. The main characteristics of JYAS-D are that it can relieve the symptoms of depression by improving the quality 
of sleep and regulating the neuroendocrine system of patients in previous clinical observation. 
In addition to monoamine neurotransmitters, hyperactivity of hypothalamic-pituitary-adrenal (HPA) axis and 
excitatory amino acids (EAAs) disorders are more recognized in pathogenesis of depression (Musazzi et al., 2013; 
Schule et al., 2009). Previous studies have proposed that hyperactivity of HPA is a result of the deficit negative 
feedback regulation of the axis which causally linked to the development of depressive symptoms and occurs 30% to 
50% among the acutely depressed patients (Schule et al., 2009). Long-term chronic stress could cause hyper-function 
of HPA which led to excessive expression of glucocorticoid receptor (GR) (Pitchot et al., 2001). The prolonged 
overproduction of Corticosterone（CORT) caused by chronic stress could damage the hippocampus neurons and induce 
depressive symptoms such as depressed mood, feeling of worthlessness, insomnia, forgetfulness, sexual dysfunction, 
and other symptoms of depression (Iijima et al., 2010; Naert et al., 2007; Pilar-Cuellar et al., 2013). Meanwhile, 
excessive stress response, through the action of glucocorticoid (GC) could induce abnormal enhancement of glutamate 
release and excitatory transmission in selective brain areas, including amygdala, hippocampus, and prefrontal cortex 
(Musazzi et al., 2013). Our previous study had indicated that JYAS-D exerted a significant antidepression effect.  
Investigations were required to identify pharmacodynamic material basis and explore its mechanism of 
anti-depression of JYAS-D. 
 
Materials and Methods 
Preparation of JYAS-D extracts 
 
JYAS-D is comprised of seven commonly used Chinese herbs (Table 1) in the ratio of 1:1.5:0.5:1:1:3 on a dry 
weight basis, respectively. The crushed herbs of Radix Bupleuri (150 g), Radix Scutellariae (225 g), Semen Ziziphi 
spinosae (450 g), Radix et Rhizoma Glycyrrhizae (75 g ), Bulbus Lilii (150 g), Rhizoma Pinelliae (150 g), and Concha 
Ostreae (450 g) purchased from the Beijing Tongrentang, a famous traditional herbal medicine store in China, were 
authenticated by Li Jia (Beijing, China). The Concha Ostreae was decocted with water (16.5 L) at boiling temperature 
for 2 h, and then the other herbal admixtures were added and kept on boiling for 2 h. After filtered, the residue was 
extracted with water (13.2 L) for 1.5 h and then filtered. The above filtrates were merged and evaporated under vacuum 
at 55 °C to obtain the concentrate (2 L). The concentrate was precipitated with 95% ethanol (4 L) and stored at -4 °C 
for 12 h. After centrifuged at 3000 rpm for 5 min, the supernatant was evaporated under vacuum at 55 °C to remove 
ethanol and obtained the aqueous extract of JYAS-D (500 mL). It was used for the following experiment and stored at 
-20 °C.  
The combined effects of herbs in a multi-herbal formula may produce a powerful curative action, and the 
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therapeutic effect is attributed to the synergistic effects of multiple constituents in the preparation. Pharmacological 
studies (Bondi et al., 2008; Liu et al., 2013; Papp, 2012; Pilar-Cuellar et al., 2013; Schweizer et al., 2009) showed that 
flavonoids from Radix Scutellariae and Radix et Rhizoma Glycyrrhizae Preparata Cum Melle have anti-viral, 
antioxidative, anti-microbial and anti-inflammatory activities. Alkaloids are representative chemicals of Rhizoma 
Coptidis (An et al., 2008). These chemicals have antibacterial, antispasmodic and antineoplastic activities (Christakis et 
al., 2012; Kakefuda et al., 2010; Mahar et al., 2014). Radix et Rhizoma Ginseng and Radix et Rhizoma Glycyrrhizae 
Preparata Cum Melle have remarkable pharmacological effects due to the bioactive saponins inside.  
 
High performance liquid chromatography (HPLC) analysis  
 
The authentic standards of spinosin, baicalin and wogonoside were purchased from Chengdu Must 
Bio-technology CO., LTD. (China) and stored at 4 °C. Acetonitrile and Formic acid (HPLC grade) were obtained from 
E. Merck (Darmstadt, Germany). The other reagents were analytical grade from Nanjing Chemical Factory (Nanjing, 
China). Water was purified using a Milli-Q water purification system (Millipore, USA). 
The content of spinosin, baicalin and wogonoside in the extract of JYAS-D was determined with an Agilent 1260 liquid 
chromatography system (Agilent Technologies, USA), consisted of an auto sampler, a quaternary pump, a diode-array 
detector, and a column temperature controller. Agilent Chem Station Version B.04.03C software was used for data 
collection and analysis. 
Before the chromatographic analysis, 0.5 mL sample was extracted with methanol (8 mL) by ultrasonic at 30 °C 
for 10 min, then diluted with methanol to 10 mL and filtrated through 0.45 μm membrane filter. The assay was 
performed on a Merck Hibar C18 column (4.6×250 mm, 5 µm) at a temperature of 30 °C, using a gradient mobile 
phase consisted of acetonitrile (solvent A) and 0.1% formic acid in water (solvent B). The linear gradient was: 0-15 
min, 99-88% B; 15-20 min, 88-85% B; 20-30 min, 85-80% B; 30-40 min, 80-72% B; 40-60 min, 72-60% B; 60-80 min, 
60-30%. The flow rate was 1.0 mL/min. The wavelength was set at 335 nm (for spinosin) and 277 nm (for baicalin and 
wogonosidein).The injection volume was 5 μL. 
The contents of spinosin, baicalin and wogonosidein in the extract of JYAS-D were 0.364 mg/mL, 5.278 mg/mL, 
2.692 mg/mL respectively (Figure 1,2,3). 
  
 
Figure 1: The chemical structures of spinosin (a), baicalin (b) and wogonosidein (c). 
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Figure 2: The HPLC chromatograms at 277 nm of the reference substance (upper) and the extract of JYAS-D (under). 
 
Figure 3: The HPLC chromatograms at 335 nm of the reference substance (upper) and the extract of JYAS-D (under). 
Table 1: Components of JYAS-D 
Plant species (Latin) Family Plant part Pinyin 
Bupleurumchinense DC. Umbelliferae Root Chaihu 
ScutellariabaicalensisGeorgi Lamiaceae Root Huangqin 
Ziziphusjujuba Mill. var. spinosa 
(Bunge) Hu ex H.F.Chou 
Rhamnaceae Seed Suanzaoren 
GlycyrrhizauralensisFisch. Leguminosae Root and rhizoma Gancao 
Lilium brownie F.E.Brown var. 
viridulum Baker 
Liliaceae Bulbus Baihe 
Pinelliaternata (Thunb.) Breit. Araceae Rhizoma Banxia 
 Concha Ostreae  Muli 
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Animals and grouping  
 
Thirty-six adult healthy male Sprague-Dawley (SD) rats weighed 180–200 g (License No. SCXK (Jing) 
2012-0001) were provided by the Vital River Laboratory Animal Technology Co., Ltd.  The animals were kept on a 
12 h/12 h light/dark cycle and given free access to food and water, and habituated to animal facilities for 1 week to 
adapt to the new environment before the experiments. All animal procedures conformed to the Guide for the Care and 
Use of Laboratory Animals and were approved by the Institutional Animal Care and Use Committee at Capital Medical 
University. Rats were assigned randomly into six groups (n=6 per group): normal, model, low-dose, middle-dose and 
high-dose of JYAS-D and control group (fluoxetine hydrochloride). Rats in normal and model groups were treated with 
saline. 
 
Model of Depression by Chronic Unpredictable Stress (CUS) (Bondi et al., 2008; Liu et al., 2013; Papp, 2012; 
Schweizer et al., 2009). 
 
Three rats per-cage were housed in the normal group without stimulus while one rat per-cage was housed in model 
group with all kinds of stress stimulation for 28 days. Stress stimulation included water deprivation(24 h), food 
deprivation (24 h), clamping the tail (1 -1.5 min), forced swim in ice water (4 °C, 5 min), Soiled cage (Pour 250 mL 
plain water into the corn straw-bedding, 24 h), converting their circadian rhythm, braking (2-3 h), water platform(4 °C, 
5 min，Height of 20 cm). 1-2 kinds of stimulation were randomly assigned daily. Each stimulus was repeated 3-4 times. 
(Table 2 a) 
Table 2:  Schedule of stressors used in 28 days of CUS procedure 
Stressor Duration Day Stressor Duration Day 
Clamping the tail  1 min 1 d Physical restraint 3 h 15 d 
Physical restraint 2 h 2 d Clamping the tail  1.5 min 16 d 
Water deprivation  23 h 3 d Forced swimming at 4 °C  5 min 17 d 
overnight illumination and noise 12 h 4 d Water platform at 4 °C 5 min 18 d 
Forced swimming at 4 °C  5 min 5 d overnight illumination and noise 12 h 19 d 
Water platform at 4 °C 5 min 6 d Food deprivation 40 h 20-21 d 
Food deprivation 40 h 7-8 d Clamping the tail  1.5 min 22 d 
Physical restraint 2 h 9 d Forced swimming at 4 °C  5 min 23 d 
Clamping the tail  1 min 10 d overnight illumination and noise 12 h 24 d 
Physical restraint 
Soiled cage  
3 h 
24h 
11 d Water deprivation  23 h 25 d 
Forced swimming at 4 °C  5 min 12 d Food deprivation 24 h 26 d 
Water platform at 4 °C 5 min 13 d 
Physical restraint 
Soiled cage  
3 h 
24 h 
27 d 
Water deprivation  23 h 14 d Water deprivation  23 h 28 d 
 (a) 
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Table 2: Schematic drawing of experimental schedule Protocol 1 (a): after one week of acclimatization, the SD rats 
were randomly divided into 6 groups of 6 rats. All rats (except rats in the normal group) were subjected to CUS. 
Protocol 1 (b): the rats were given JYAS-D and fluoxetine by continuously intra-gastric administration for 28 days 
when the chronic unpredictable stress occurred. The sucrose preference was observed at 1 d,14 d and 28 dafter the 
model establishment.The behavior changes of rats were observed by the open field test. 
 
 
 
 
 
 
 
 
 
 
 
Note: (1) SPT: sucrose preference test;(2) OFT: Open field test 
(b) 
 
Reagents and drugs administration 
 
Prozac (fluoxetine hydrochloride dispersible tablets, pantheons France company, France, Lot: 2090A, 20 
mg/tablet), was used in concentration to 2 mg/mL liquid by distilled water. The model group was normally fed after 
28-day stress stimulation without any treatment. JYAS-D groups and fluoxetine group were subjected to a model of 
chronic unpredictable stress and fed isolation. JYAS-D was orally administered 8.2 g/kg, 16.3 g/kg 32.7 g/kg 
respectively once per day through gastric perfusion. Fluoxetine was dissolved into 2 mL normal saline and was orally 
administered 10mg/kg through gastric perfusion. The treatment lasted for 28 days. All rats were included in the final 
analysis. (Table 2 b) 
 
Sucrose preference test 
 
Sucrose preference test (An et al., 2008; Mahar et al., 2014) was employed herein to determine anhedonia, one of 
the core symptoms of major depression in human. The procedure was composed of training and testing courses. After 1 
week of acclimatization, the rats were trained to drink 1% (w/v) sucrose solution before the start of the CUS protocol. 
In the training course, the rats were deprived of food and water for 48 h and only exposed to1% (w/v) sucrose solution. 
Three days later, after 23 h food and water deprivation, 1 h baseline test was performed, in which rats could select 
between two pre-weighted bottles, one with 1% (w/v) sucrose solution and the other with tap water. Then the 
preference percentage of sucrose was calculated according to the following formula: 
Preference percentage= (sucrose intake (g) / (sucrose intake (g) +water intake (g)) ×100% 
Finally, on 14th day and the end of the experiment, the sucrose preference test was performed to evaluate the CUS 
model and drugs action. 
 
Behavior observation 
 
An open-field (Christakis et al., 2012; Liang et al., 2013; Kakefuda et al., 2010) method was used to conduct 
Drug administration Acclimatization 
SPT 
(training & texting) 
7 days 14 days 14 days 
3 days 
SPT 
OFT 
 
SPT 
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behavior test with a software monitoring animal spontaneous activity (JLBehv-LG, made in Shanghai) in all group rats. 
The open-field device was made of opaque materials with 40 cm× 40 cm× 45 cm cube. The rat was put in the central 
square. The spontaneous activity of the rat was recorded in 10 minutes. The field was cleaned thoroughly and sprayed 
with 75% alcohol at intervals.  
 
Radiation immunity analysis (RIA) method 
 
3 mL blood was taken from rats and then centrifugated (4 °C, 10000 RPM, 10 min). Serum of rats were separated 
and stored at -20 °C. RIA was applied to examine the serum level of corticosterone CORT, ACTH and CRH.  
 
Enzyme linked immunosorbent assay (ELISA) method 
 
Rats from each group were sacrificed after anesthesia, the whole brain was then removed. Hippocampus of rats 
was divided and rinsed in ice-cold PBS (0.02mol/L, pH 7.0-7.2) to remove excess blood thoroughly and weighed 
before homogenization. Samples were stored at -20 °C. The contents of GR and MR in hippocampus were measured by 
using commercially available ELISA kits according to the manufacturer’s instructions. Determined the Optical Density 
(OD.) values at 450 nm using a kind of micro-plate reader. 
 
OPA (Ortho-phthalaldehyde) derivatization method 
 
OPA derivatization method was used to detect the contents of amino acid neurotransmitter (Glu, γ-GABA) in 
hippocampus. Rat hippocampus were weighed and homogenized in 5% ethanol (1:9). Chromatographic column: 
Agilent C18 chromatographic column (5 μm, 4.6*25 cm); Mobile phase: A phase; PH 6.5 potassium dihydrogen 
phosphate buffer solution (0.025 mol/L), phase B: methanol; Flow rate: 1.0 mL/min; Column temperature: 35°C; 
Sample quantity: 10μL; Fluorescence detection conditions: the excitation wavelength of 357 nm, emission wavelength 
of 455 nm.  
 
Statistical Analysis 
 
All results are calculated with means ± SD. The variance analysis was used to compare the differences among 
groups. The change weight was calculated on the repeated measures analysis of variance. If P value is less than 0.05, 
the difference was considered statistically significant. We use test for homogeneity to examine the data: if the data is 
homogeneous, we conduct analysis of variance (one-way ANOVA) directly on the data. Between the two groups, we 
used the LSD method to compare any difference. All statistical analyses were carried out by using SPSS for Windows 
(SPSS 15). 
 
Results 
Body weight 
 
Before model establishment at 1 d, there were no significant differences of weights in rats among all of the groups 
(P>0.05). In the period of model establishment, the weights of rats were examined at 6 d, 11 d, 16 d, 19 d, 22 d, 25 d 
and 28 d. The weights of rats were decreased in model group compared with those of the normal group (P<0.05). 
JYAS-D and fluoxetine could not alleviate the CUS-induced weight reduction. (Figure 4 a) 
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Sucrose Preference 
 
The sucrose preference was measured at 1 d, 14 d and 28 d. There was no significant difference before treatment 
in all of groups (P>0.05). At 14 d of model establishment, compared with the normal group, the sucrose preference was 
decreased in model group (P<0.05). At 28 d of model establishment, the sucrose preference was decreased in model 
group. The sucrose preference was significantly increased among the low, mid, high-dose JYAS-D group and 
fluoxetine group (P<0.05) at 28 d. (Figure 4 b) 
 
 
Figure 4: Effects of JYAS-D on body weight (a) and Sucrose preference of rats with CUS (b). 
The weights of rats were decreased in model group compared with those of the normal group at 6 d, 11 d, 16 d, 19 d, 22 
d, 25 d and 28 d; The sucrose preference was decreased in model group (P<0.05) at 14 d of model establishment 
compared with the normal group. At 28 d of model establishment, the sucrose preference was significantly increased 
among the low, mid, high-dose JYAS-D group and fluoxetine group (P<0.05) at 28 d. 
 
Open-Field Test (OFT)  
 
There was a significant difference in the open-field test among these groups. Compared with the normal group, 
there were significant increases of the proportion of central active distance and the central time in model group(P<0.05). 
The proportion of edge active distance and edge time were significantly decreased in model group(P<0.05). Compared 
with the model group, the proportion of central active distance was decreased and edge active distance was increased 
among the low, mid, high-dose JYAS-D and fluoxetine group(P<0.05); the central active time was decreased and the 
edge active time was increased among the low, high-dose JYAS-D and fluoxetine group (P<0.05) (Figure 5). 
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Figure 5: Effects of JYAS-D on open-field test of rats with CUS. A series of the behavior changes in rats were 
observed by the open field test and the following parameters were measured: central distance / total distance, edge 
distance / total distance, central active time and edge active time. Data are expressed as mean ±SD, n = 6 per group. 
△p< 0.05 versus normal, ∗p< 0.05versus model. 
 
 
 
Serum concentrations of CORT, ACTH and CRH 
 
The serum concentration of CRH, ACTH and CORT were significantly increased in model group. Compared with 
the normal group, the contents of CORT, ACTH and CRH in serum were increased in model group (P<0.05). 
Compared with the model group, the concentration of CORT in serum was significantly reduced in the middle dose 
JYAS-D group and fluoxetine group (P<0.05). The concentration of ACTH in serum was significantly reduced in the 
low and high-dose JYAS-D group in comparison with the model group (P<0.05). The concentration of CRH in serum 
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reduced significantly in the middle and high-dose JYAS-D group in comparison with the model group (P<0.05) (Figure 
6 a, b, c).  
 
 
Figure 6: Effects of JYAS-D on serum CRH, ACTH, CORT and hippocampus GR，MR，Glu，γ-GABA，Glu/γ-GABA 
in depressive rats. Data are expressed as mean ± SD, n= 6 per group.△p< 0.05 versus normal,∗p< 0.05 versus model. 
ACTH: adrenocorticotropic hormone; CORT: corticosterone; CRH: corticotropin-releasing hormone; GR: 
Glucocorticoid receptor; MR: Mineralocorticoid receptor; Glu: Glutamic acid; γ-GABA: γ-aminobutyricacid. 
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Hippocampus contents of GR and MR 
 
Compared with the normal group, the hippocampus content of GR decreased significantly in model group 
(P<0.05). Compared with the model group, the content of GR in hippocampus increased significantly in the middle and 
high dose JYAS-D group (P<0.05);the content of MR reduced significantly in the mid, high-dose JYAS-D group and 
fluoxetine group (P<0.05) (Figure 6 d, e).  
 
Hippocampus contents of Glu and γ-GABA 
 
Compared with the normal group, the contents of γ-GABA in hippocampus was significantly reduced in model 
group (P<0.05). The proportion of Glu/γ-GABA was increased in model group (P<0.05). Compared with the model 
group, the content of Glu in hippocampus was decreased among the low, middle, high dose JYAS-D group and 
fluoxetine group (P<0.05). The proportion of Glu/γ-GABA was reduced in the low and high-dose JYAS-D group 
(P<0.05) (Figure 6 f, g).  
 
Discussion 
  
Chronic Unpredictable Stress is widely used in scientific research of depression animal model simulating core 
symptoms of depression - reward reactivity decreased (anhedonia) (Dai et al., 2010; Luo et al., 2008; Mao et al., 2010; 
Willner, 1986). This study found that the weight of model group was significantly lower than that of normal group 
(P<0.05). Anhedonia occurred in 95% of the depression patients (Keller et al., 1995). Sucrose preference test can be 
used to evaluate anhedonia of CUS model rats (Grippo et al., 2004; Gronli et al., 2005). Sucrose preference in CUS 
model rats were decreased obviously after chronic stress (Shimamoto et al., 2011; Zurita et al., 2000). This study also 
found sucrose preference in model group was significantly lower than that of normal group after 14 d and 28 d 
(P<0.05). Sucrose preference was significantly restored by the administration of JYAS-D. OFT is one of the most 
popular assessment methods in behavioral research and can be used to evaluate the environmental manipulations 
applied on the emotions of rodents (Liang et al., 2013; Ma et al., 2011). The results of our experiment found that 
JYAS-D could alleviate the spontaneous activity. 
Studies have suggested that increased serum levels of GC (CORT in rodents), ACTH and CRH are associated with 
an increased risk of depression (Paredes et al., 2007; Viinamaki et al., 2012). Chronic unpredictable stress can lead to 
dysfunction of HPA axis. CORT, ACTH and CRH in rats increased significantly through chronic stress exposure. A 
large secretion of CORT is one of he most important feature of stress response. Chinese herbs could significantly 
reduce the serum levels of CRH, CORT and ACTH in the depressed mouse model (Chen et al., 2013). In our 
experiment, serum levels CORT, ACTH and CRH were increased in CUS model rats, while JYAS-D could significantly 
reduce serum levels of CORT, ACTH and CRH.  
Hippocampus, known to contain high density of GR and MR (Rybnikova et al., 2007), is the key structure in the 
inhibition of stress-induced HPA axis activation, and is also more sensitive to glucocorticoid mediated impairment. 
Hippocampus can affect HPA mainly by regulating concentrations of MR and GR. MR is high affinity with 
endogenous GC. MR can be combined with the GC of physiological level to regulate HPA axis. The GR is low affinity 
with GC, but GR can combine excessive of GC and make the hyper-function HPA axis back to normal. Therefore, GR 
played an important role to regulate high concentrations of GC. Prolonged overproduction of CORT could damage 
hippocampus neurons leading to atrophy and apoptosis of hippocampal neurons (Urbach et al., 2008; Xiu et al., 2008).  
Excessive CORT could induce the decline of GR in the hippocampus which in turn could reduce the negative 
feedback regulation in HPA axis. On the other hand, excessive CORT could promote the sustaining hyper-secretion of 
Quixia et al., Afr J Tradit Complement Altern Med., (2017) 14 (2): 33-46 
doi:10.21010/ajtcam.v14i2.5 
44 
 
glucocorticoids (this process is also known as the glucocorticoid cascade hypothesis) (Pariante and Lightman, 2008). 
The weakened effects of the negative feedback regulation in HPA axis would worsen the symptoms of depression 
patients (Schule et al., 2009). In animals, chronic stress paradigms have been evidenced to down-regulate hippocampus 
GR number (An et al., 2011). The content of hippocampus GR decreases and then a large secretion of CORT occurs 
which together manifest the hyperactivity. Feedback inhibition of HPA axis is often impaired in chronic stress rats. In 
the present study, we have found that the content of hippocampus GR in rats was significantly reduced by CUS 
procedure. JYAS-D could increase the content of GR in hippocampus significantly. In our experiment, no significant 
difference has been found in the content of hippocampus MR between normal group and model group. 
CORT could promote the hyper-secretion of excitatory amino acids, and release to specific areas of the brain, such 
as amygdala, hippocampus and prefrontal cortex (Musazzi et al., 2013). Glu is one of the excitatory amino acid. 
Excessive Glu could produce excitatory neurotoxicity and damage to hippocampus neurons. γ-GABA is generally 
considered as an important inhibitory amino acid in brain of mammals which is closely associated with mental activity 
(Lee et al., 2010). The increase of γ-GABA could inhibit the excitatory neurons, attenuate the excessive synthesis of 
Glu and block the excitatory neurotoxicity of Glu. γ-GABA could protect hippocampal neurons and have the effect of 
antidepressant. Chronic stress might cause excessive CORT, and consequently, the Glu would aggregate outside 
hippocampal neurons, which leads to the death of hippocampal neuron (Lee et al., 2007). Previous researches have 
shown that the level of hippocampus Glu in depression rats significantly increases (Reagan et al., 2012) and γ-GABA 
decreases significantly (Catenadell'Osso et al., 2013; Walker et al., 2013). The content of γ-GABA in hippocampus has 
been reduced and the proportion of Glu/γ-GABA in hippocampus has increased in model group in our experiment. 
JYAS-D could reduce excitatory neurotoxicity of excessive Glu and regulate the equilibrium of ratio of amino acids 
neurotransmitter. 
Collectively, this study has demonstrated that JYAS-D could produce a significant antidepressant effect in CUS 
model rats through down-regulating serum concentration of CORT, ACTH and CRH levels, increasing content of 
hippocampus GR and regulating the equilibrium of proportion of amino acids neurotransmitter. Therefore, JYAS-D 
might serve as a novel antidepressant in future clinical practices. 
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